Registry-based Clinical Trials (Reg-CTs): A Training Program
Providing Registry-based Clinical Trial (Reg-CT) related training to our workforce to increase the number of Reg-CTs available nationally.
Aim:
This course aims to increase our clinical trial workforce and enable clinical trial professionals to conduct more Reg-CTs which in turn increases access to clinical trials for patients.
Learning Objectives:
The Registry-Based Clinical Trials (Reg-CTs) training modules will provide an overview of the Reg-CTs model and how it differentiates from current clinical trial models by:
-
Defining Registry-based Clinical Trials and how they are run.
-
Exploring how Registry-based Clinical Trial bridge the gap by combining conventional trial methodology with a clinical registry to answer real world clinical questions.
-
Defining how a clinical registry works and the integration of randomised controlled trials into registry frameworks.
-
Explaining the distinct process for conducting Registry-based Clinical Trials
Learning Outcomes:
By the end of this training program, our workforce will be able to:
-
Examine the characteristics of Registry-based Clinical Trials.
-
Differentiate between Registry-based Clinical Trials and conventional clinical trials.
-
Consider the advantages of Registry-based Clinical Trials for participants.
-
Determine the distinct process for conducting Registry-based Clinical Trials.
Course Contributors
Dr. Shehara Mendis - Medical Oncologist at Cabrini Health and Western Health, Honorary Clinical Research Fellow at Melbourne Health and Monash Health, Clinical Research Fellow, Personalised Oncology Division, Walter & Eliza Hall Institute of Medical Research
Michael Harold - Senior Project Manager for the Gibbs Lab, Walter & Eliza Hall Institute of Medical Research
Dr. Vanessa Wong - Clinical Research Fellow, Personalised Oncology Division, Walter & Eliza Hall Institute of Medical Research, Medical Oncologist at Ballarat Health Services and Western Health
Bill Karanatsios - Research Program Director, Western Health
In addition with:
Eleonora Kay - Clinical Trial Innovations, VCCC Alliance
Duncan Colyer - Senior Manager for Research, VCCC Alliance
Alicia Mew - eLearning Developer, Education, VCCC Alliance
Professor Peter Gibbs - Medical Oncologist, Joint Division Head, Personalised Oncology, Walter & Eliza Hall Institute of Medical Research and Program 4 Clinical Trial Innovations Co-chair
Dr Sweet Ping - Radiation Oncologist, Austin Health
Professor Bruce Mann - Surgical Oncologist and Specialist Breast Surgeon; Director of Breast Cancer Services for the Royal Melbourne and Royal Women's Hospitals and a Professor of Surgery at the University of Melbourne.
Professor Jennifer Phillip - Chair, Palliative Medicine, Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne; St Vincent's Hospital
Dr Vanessa Wong - Clinical Research Fellow, Personalised Oncology Division, Walter & Eliza Hall Institute of Medical Research, Medical Oncologist at Ballarat Health Services and Western Health
Professor Sue Evans - Director, Victorian Cancer Registry, Cancer Council Victoria
Associate Professor Craig Underhill - Medical oncologist, Clinical Director of Oncology Services at Albury Wodonga Health, and Clinical Director of Hume Regional Integrated Cancer Services, VCCC Alliance Regional Oncology Lead.
Bill Karanatsios - Research Program Director, Western Health
Michael Harold - Senior Project Manager for the Gibbs Lab, Walter & Eliza Hall Institute of Medical Research
Michelle Barrett - Head of Education, VCCC Alliance
Dr Shehara Mendis - Medical Oncologist at Cabrini Health and Western Health, Honorary Clinical Research Fellow at Melbourne Health and Monash Health, Clinical Research Fellow, Personalised Oncology Division, Walter & Eliza Hall Institute of Medical Research
Di Hughes - Clinical Trial Co-ordinator, Bendigo Cancer Centre
Eleonora Kay - Clinical Trial Innovations, VCCC Alliance
Duncan Colyer - Senior Manager for Research, VCCC Alliance
Course Details
This course is brought to you by
